Hyperinsulinism
2 papers
- Human trial2
Trial sponsors
1 trialPhase 120 people
1 trialEarly phase 130 people
Latest
Diabetes Care
Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone
Randomised trial in 94 peopleInterventions